|
|
|
Volumn 24, Issue 11, 1997, Pages 1571-1577
|
|
Protein synthesis inhibitor - Antitumor activity and mode of action of KRN 5500
a
|
|
Author keywords
Human xenografts; KRN 5500; Protein synthesis inhibitor; Spicamycin derivative
|
|
Indexed keywords
6 [4 DEOXY 4 (2,4 TETRADECADIENOYLGLYCYLAMINO) GLYCERO BETA MANNOHEPTOPYRANOSYLAMINO] 9H PURINE;
ANTINEOPLASTIC AGENT;
DOXORUBICIN;
DRUG METABOLITE;
MITOMYCIN C;
PHORBOL 13 ACETATE 12 MYRISTATE;
PROTEIN SYNTHESIS INHIBITOR;
PUROMYCIN;
SPICAMYCIN;
UNCLASSIFIED DRUG;
VINCRISTINE;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER CELL CULTURE;
CANCER INHIBITION;
COLON CANCER;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG MECHANISM;
DRUG STRUCTURE;
HUMAN;
HUMAN CELL;
LIVER METASTASIS;
MOUSE;
NONHUMAN;
NUDE MOUSE;
PROTEIN SYNTHESIS INHIBITION;
RABBIT;
RAT;
RETICULOCYTE LYSATE;
SCID MOUSE;
ANIMALS;
ANTIBIOTICS, ANTINEOPLASTIC;
BREAST NEOPLASMS;
CELL DIVISION;
COLONIC NEOPLASMS;
HUMANS;
LUNG NEOPLASMS;
MICE;
NEOPLASM TRANSPLANTATION;
PROTEIN SYNTHESIS INHIBITORS;
PURINE NUCLEOSIDES;
RABBITS;
STOMACH NEOPLASMS;
TUMOR CELLS, CULTURED;
|
|
EID: 0030814911
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (20)
|
